Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model
- PMID: 15826835
- DOI: 10.1016/j.semcancer.2005.01.006
Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model
Abstract
Chromosomal translocations entail the generation of gene fusions in mesenchymal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype still remains to be elucidated. Here these studies are reviewed, using FUS-DDIT3 as a model to illustrate how they have contributed to current understanding in unique and unexpected ways. FUS-DDIT3 is a chimeric oncogene generated by the most common chromosomal translocation t(12;16)(q13;p11) associated with liposarcomas. The application of transgenic methods to the study of this sarcoma-associated FUS-DDIT3 gene fusion has provided insights into their functions in vivo, and suggested mechanisms by which lineage selection may be achieved.
Similar articles
-
Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.Carcinogenesis. 2007 Oct;28(10):2069-73. doi: 10.1093/carcin/bgm107. Epub 2007 Apr 29. Carcinogenesis. 2007. PMID: 17468515
-
Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.Oncogene. 2000 Dec 7;19(52):6015-22. doi: 10.1038/sj.onc.1204018. Oncogene. 2000. PMID: 11146553
-
Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.Ann Diagn Pathol. 2006 Feb;10(1):36-8. doi: 10.1016/j.anndiagpath.2005.04.006. Ann Diagn Pathol. 2006. PMID: 16414544
-
[Current idea of the morphogenetic features of liposarcomas].Arkh Patol. 2012 Nov-Dec;74(6):61-3. Arkh Patol. 2012. PMID: 23383449 Review. Russian.
-
FUS::DDIT3 Fusion Protein in the Development of Myxoid Liposarcoma and Possible Implications for Therapy.Biomolecules. 2024 Oct 14;14(10):1297. doi: 10.3390/biom14101297. Biomolecules. 2024. PMID: 39456230 Free PMC article. Review.
Cited by
-
Advances in the targeted therapy of liposarcoma.Onco Targets Ther. 2015 Jan 5;8:125-36. doi: 10.2147/OTT.S72722. eCollection 2015. Onco Targets Ther. 2015. PMID: 25609980 Free PMC article. Review.
-
Mechanical Strain Induces Transcriptomic Reprogramming of Saphenous Vein Progenitors.Front Cardiovasc Med. 2022 May 27;9:884031. doi: 10.3389/fcvm.2022.884031. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35711359 Free PMC article.
-
Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency.PLoS One. 2019 May 9;14(5):e0216674. doi: 10.1371/journal.pone.0216674. eCollection 2019. PLoS One. 2019. PMID: 31071190 Free PMC article.
-
Animal models of soft-tissue sarcoma.Dis Model Mech. 2010 Sep-Oct;3(9-10):557-66. doi: 10.1242/dmm.005223. Epub 2010 Aug 16. Dis Model Mech. 2010. PMID: 20713645 Free PMC article. Review.
-
FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.PLoS One. 2008 Jul 2;3(7):e2569. doi: 10.1371/journal.pone.0002569. PLoS One. 2008. PMID: 18596980 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials